FR5267M - - Google Patents

Info

Publication number
FR5267M
FR5267M FR54286A FR54286A FR5267M FR 5267 M FR5267 M FR 5267M FR 54286 A FR54286 A FR 54286A FR 54286 A FR54286 A FR 54286A FR 5267 M FR5267 M FR 5267M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR54286A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of FR5267M publication Critical patent/FR5267M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR54286A 1965-03-23 1966-03-21 Expired FR5267M (Sortimente)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44220565A 1965-03-23 1965-03-23
US57654966A 1966-09-01 1966-09-01
US734770A 1970-01-28 1970-01-28

Publications (1)

Publication Number Publication Date
FR5267M true FR5267M (Sortimente) 1967-07-31

Family

ID=27358345

Family Applications (1)

Application Number Title Priority Date Filing Date
FR54286A Expired FR5267M (Sortimente) 1965-03-23 1966-03-21

Country Status (5)

Country Link
US (1) US3609152A (Sortimente)
BE (1) BE678216A (Sortimente)
DE (1) DE1620127C3 (Sortimente)
FR (1) FR5267M (Sortimente)
GB (3) GB1062357A (Sortimente)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1383409A (en) * 1972-09-09 1974-02-12 Pfizer Ltd Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them
DE2847693A1 (de) * 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
US4625026A (en) * 1982-12-30 1986-11-25 Biomeasure, Inc. 2-amino-4-oxo-tricyclicpyrimidines having antiviral activities against herpes simplex virus type II infections
JPS6442472A (en) * 1987-08-10 1989-02-14 Kanebo Ltd Quinazoline derivative, production thereof and brain function disorder improving agent containing said derivative as active ingredient
US4877790A (en) * 1987-12-15 1989-10-31 Kanebo Limited Quinazoline derivative, processes for its production, and cerebral dysfunction remedying agent comprising it as active ingredient
TW334434B (en) * 1995-05-16 1998-06-21 Kanebo Ltd Novel quinazoline compound and anti-tumor agent
WO1997042192A1 (de) * 1996-05-07 1997-11-13 Basf Aktiengesellschaft Imidazo-chinazoline, sie enthaltende mittel und deren verwendung zur bekämpfung von schadpilzen und tierischen schädlingen
DE60110844T2 (de) * 2001-01-02 2006-01-12 F. Hoffmann-La Roche Ag Chinazolone derivate als alfa 1a/b adrenozeptor antagonisten
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
EP1389224B1 (en) * 2001-05-14 2010-01-13 Omnova Soltions Inc Polymeric surfactants derived from cyclic monomers having pendant fluorinated carbon groups
EP1398032A1 (en) * 2002-09-10 2004-03-17 PheneX Pharmaceuticals AG 4-Oxo-quinazolines as LXR nuclear receptor binding compounds
EP1407774A1 (en) * 2002-09-10 2004-04-14 LION Bioscience AG 2-Amino-4-quinazolinones as LXR nuclear receptor binding compounds
DK1557414T3 (da) 2002-10-01 2012-05-29 Mitsubishi Tanabe Pharma Corp IsoquinoIin-forbindelser og medicinsk anvendelse deraf
ATE540928T1 (de) 2002-11-22 2012-01-15 Mitsubishi Tanabe Pharma Corp Isochinolinverbindungen und ihre medizinische verwendung
US7928104B2 (en) 2003-11-20 2011-04-19 Dominique Jean-Pierre Mabire 7-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
AU2004295058B9 (en) 2003-11-20 2011-06-30 Janssen Pharmaceutica N.V. 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
NZ551801A (en) 2004-06-30 2009-11-27 Janssen Pharmaceutica Nv Quinazolinedione derivatives as PARP inhibitors
NZ551799A (en) 2004-06-30 2009-11-27 Janssen Pharmaceutica Nv Phthalazine derivatives as PARP inhibitors
ATE498613T1 (de) 2004-06-30 2011-03-15 Janssen Pharmaceutica Nv Chinazolinonderivate als parp-hemmer
CN102372704B (zh) * 2005-02-18 2014-10-08 田边三菱制药株式会社 脯氨酸衍生物的盐，其溶剂合物，及其生产方法
PL2007752T3 (pl) 2006-03-31 2011-02-28 Janssen Pharmaceutica Nv Benzoimidazol-2-ilopirymidyny i pirazyny jako modulatory receptora histaminowego H4
JP5545955B2 (ja) 2007-03-08 2014-07-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ Ｐａｒｐおよびｔａｎｋ阻害剤としてのキノリノン誘導体
EP2215075B1 (en) 2007-10-26 2013-12-11 Janssen Pharmaceutica, N.V. Quinolinone derivatives as parp inhibitors
RU2490260C2 (ru) 2008-03-27 2013-08-20 Янссен Фармацевтика Нв Тетрагидрофенантридиноны и тетрагидроциклопентахинолиноны в качестве ингибиторов parp и ингибиторов полимеризации тубулина
WO2009118384A1 (en) 2008-03-27 2009-10-01 Janssen Pharmaceutica Nv Quinazolinone derivatives as tubulin polymerization inhibitors
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
EA020090B1 (ru) * 2008-06-30 2014-08-29 Янссен Фармацевтика Нв Способ получения и рекристаллизации кристаллического гемитартрата бензоимидазол-2-илпиримидинового производного
US9040508B2 (en) 2008-12-08 2015-05-26 Vm Pharma Llc Compositions of protein receptor tyrosine kinase inhibitors
US8987444B2 (en) * 2010-01-18 2015-03-24 Msn Laboratories Private Limited Process for the preparation of amide intermediates and their use thereof
WO2012131706A1 (en) * 2011-03-20 2012-10-04 Cadila Healthcare Limited Amorphous form of vilazodone hydrochloride and process for its preparation
DE102011113749A1 (de) * 2011-09-14 2013-03-14 Aicuris Gmbh & Co. Kg Sulfonsäuresalze Heterocyclylamid-substituiertr Imidazole
JP2014528427A (ja) * 2011-09-30 2014-10-27 ヤンセン ファーマシューティカ エヌ．ベー． （１−（４−フルオロフェニル）−１ｈ−インドール−５−イル）−（３−（４−（チアゾール−２−カルボニル）ピペラジン−１−イル）アゼチジン−１−イル）メタノンの結晶性塩酸塩、並びに疼痛及び代謝障害の処置におけるその使用
ES2698298T3 (es) 2012-03-15 2019-02-04 Celgene Car Llc Sales de un inhibidor de quinasa receptor de factor de crecimiento epidérmico
JP6317319B2 (ja) * 2012-03-15 2018-04-25 セルジーン シーエーアール エルエルシー 上皮成長因子受容体キナーゼ阻害剤の固体形態
US20130261134A1 (en) * 2012-03-30 2013-10-03 Boehringer Ingelheim International Gmbh Mesylate salt forms of a potent hcv inhibitor
PE20151274A1 (es) 2013-02-08 2015-09-12 Celgene Avilomics Res Inc Inhibidores de erk y sus usos
UY35370A (es) 2013-03-06 2014-09-30 Janssen Pharmaceutica Nv Moduladores benzoimidazol-2-il pirimidina del receptor de histamina h4
US8999992B2 (en) 2013-03-15 2015-04-07 Vm Pharma Llc Crystalline forms of tryosine kinase inhibitors and their salts
SG11201604517WA (en) * 2013-12-03 2016-07-28 Amgen Inc Crystalline forms of n-(4-((3-(2-amino-4-pyrimidinyl) - 2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-1 -phthalazinamine pharmaceutically acceptable salts and uses thereof
DK3179858T3 (da) 2014-08-13 2019-07-22 Celgene Car Llc Forme og sammensætninger af en ERK-inhibitor
JP2017529356A (ja) 2014-09-17 2017-10-05 ムンディファーマ インターナショナル コーポレイション リミテッド チロシンキナーゼ阻害剤及びその塩の結晶形態
CN112645933B (zh) * 2016-03-22 2022-02-11 江苏豪森药业集团有限公司 Egfr抑制剂游离碱或其酸式盐的多晶型、其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3274194A (en) * 1963-03-29 1966-09-20 Miles Lab Quinazolinedione derivatives
US3301855A (en) * 1963-04-22 1967-01-31 Ciba Geigy Corp Derivatives of 4-nu-(2-nu, nu-dimethylaminolower alkyl)-amino quinazoline
DE1249281B (Sortimente) * 1963-05-18
US3257400A (en) * 1964-06-10 1966-06-21 Searle & Co 2-amino-5, 6-dihydrobenzo[h]quinazolin-4(3h)-one and congeners

Also Published As

Publication number Publication date
GB1174273A (en) 1969-12-17
DE1620127A1 (de) 1970-03-12
BE678216A (Sortimente) 1966-09-22
GB1062357A (en) 1967-03-22
US3609152A (en) 1971-09-28
GB1174272A (en) 1969-12-17
DE1620127B2 (de) 1974-01-17
DE1620127C3 (de) 1974-10-10

Similar Documents

Publication Publication Date Title
FR5267M (Sortimente)
BE666875A (Sortimente)
BE673125A (Sortimente)
JPS4412443Y1 (Sortimente)
NO135431C (Sortimente)
JPS445023Y1 (Sortimente)
JPS4510613Y1 (Sortimente)
JPS456839Y1 (Sortimente)
JPS4416967Y1 (Sortimente)
BE671653A (Sortimente)
BE674646A (Sortimente)
BE674374A (Sortimente)
BE674365A (Sortimente)
BE674278A (Sortimente)
BE673904A (Sortimente)
BE669577A (Sortimente)
BE673736A (Sortimente)
BE673503A (Sortimente)
BE673393A (Sortimente)
BE673039A (Sortimente)
BE672914A (Sortimente)
BE672210A (Sortimente)
BE672147A (Sortimente)
BE671947A (Sortimente)
BE674477A (Sortimente)